Peptide derivatives of exendin-4

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8268781
APP PUB NO 20090180953A1
SERIAL NO

11712978

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In the current invention peptides, which are derived from GLP-1 (glucagon-like peptide-1) and exendin-3 and/or exendin-4, are provided which bond to the GLP-receptor and can be used, labeled or unlabeled, for the production of an agent for diagnostic and therapy of benign and malignant diseases, in which GLP-1 receptor expression plays a role.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PHILIPPS-UNIVERSITAT MARBURG35037 MARBURG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Béhé, Martin Marburg, DE 2 41
Behr, Thomas Marburg, DE 15 140
Göke, Burkhard J Gauting, DE 2 41
Gotthardt, Martin Kirchhain, DE 2 77

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 27 Citation Count
  • C07K Class
  • 89.83 % this patent is cited more than
  • 13 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges2601008224842719198431401 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +050100150200250300350400450500550600650700750800850900950100010501100

Forward Cite Landscape

Load Citation